Guardant Health files Form 144 for cashless exercise

Guardant Health, Inc. reported a Form 144 notice regarding the sale resulting from an employee stock option exercise on 05/22/2026.

Rhea-AI Filing Summary

Guardant Health, Inc. reported a Form 144 notice regarding the sale resulting from an employee stock option exercise on 05/22/2026. The transaction was handled via Charles Schwab & Co., Inc. as a broker payment for cashless exercise of common stock.

Key Figures

Transaction date: 05/22/2026 Broker: Charles Schwab & Co., Inc. Transaction type: Broker payment for cashless exercise +2 more

5 metrics

Transaction date 05/22/2026 Employee Stock Option Exercise date

Broker Charles Schwab & Co., Inc. Broker listed for the transaction

Transaction type Broker payment for cashless exercise Method of settlement for the option exercise

Numeric string 1 19091422.00 Numeric value present in the excerpt (label not specified)

Numeric string 2 132599929 Numeric value present in the excerpt (label not specified)

Key Terms

Employee Stock Option Exercise, Broker Payment for Cashless Exercise, Form 144

3 terms

Employee Stock Option Exercise financial

"Employee Stock Option Exercise - See Remarks"

Broker Payment for Cashless Exercise financial

"Broker Payment for Cashless Exercise"

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Guardant Health's (GH) Form 144 disclose?

It discloses an employee stock option exercise resulting in shares sold, reported on 05/22/2026. The filing lists a cashless exercise processed through Charles Schwab & Co., Inc., indicating the broker handled the share payment mechanics for the option holder.

Who executed the transaction reported on the Form 144 for GH?

The filing shows the transaction was processed by Charles Schwab & Co., Inc. on behalf of the option holder. It is described as a broker payment for cashless exercise of employee stock options on 05/22/2026.

Does the Form 144 state how many Guardant Health shares were sold?

The provided excerpt does not present a clearly labeled count of shares sold. The filing text includes numeric strings but no explicit sentence tying a share quantity to the sale; the document identifies the action as an employee option exercise on 05/22/2026.

Will Guardant Health receive proceeds from this transaction?

The excerpt describes a cashless exercise, which typically routes shares through a broker to cover exercise costs. The filing does not state whether the issuer receives proceeds; the text specifies broker payment for cashless exercise via Charles Schwab.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/22/2026 - 05:44 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001562135
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Guardant Health, Inc.
SEC File Number	001-38683
Address of Issuer	3100 HANOVER STREET PALO ALTO CALIFORNIA 94304
Phone	855-698-8887
Name of Person for Whose Account the Securities are To Be Sold	EAGLE CRAIG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Former Affiliate

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	160817	19091422.00	132599929	05/22/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/22/2026	Employee Stock Option Exercise - See Remarks	Guardant Health, Inc.			160817	05/22/2026	Broker Payment for Cashless Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks	The shares reported in this filing may be sold over various dates.
Date of Notice	05/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	CRAIG EAGLE
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)